Posted 12th October 2018 by Jane Williams
Having a powerful set of tools is essential in life science research so we’ve compiled the best free platforms for genetic engineers, molecular and synthetic biologists.
Posted 4th December 2017 by Jane Williams
Recently Baker and Lithgow (Baker, 2016; Lithgow, et al., 2017) highlighted the problem of the reproducibility in research. Reproducibility criticality affects to different extent a large portion of the science fields (Baker, 2016). Bioinformatics is becoming a key element of many biological/medical studies (Searls, 2010) and reproducibility is also an important issue in this field (Kanwal, et al., 2017; Sandve, et al., 2013).
Posted 27th November 2017 by Jane Williams
The human skin is densely colonised with a complex microbial community (1). Microbes are a part of the skin barrier that, combined with innate immunity, keeps the balance essential to maintaining healthy skin (2). Recent and independent research projects strongly suggested that human skin microbiota is of a major importance for human health and could be targeted to improve the skin health.
Posted 20th November 2017 by Jane Williams
Recent step change advances in sequencing technologies have delivered a near-complete lexicon of genomic cancer drivers. In parallel, progress in synthetic chemistry has facilitated the assembly of a broad armamentarium of molecularly-targeted therapies. However, whilst immunotherapy agents have produced notable benefits for subgroups of patients, the impact of molecularly-targeted therapies have been relatively modest.
Further unlocking the undeniable power of genomics in cancer will involve both the systematic removal of barriers and the avoidance of distractions that obscure progress. Both of which are discussed here.
Posted 18th September 2017 by Jane Williams
Launched in 1990, the Human Genome Project involved thousands of scientists across the globe and took 13 years to complete. Using capillary electrophoresis-based Sanger sequencing, it cost nearly $3 billion. In 2014 Illumina announced the first technology that could sequence a whole genome for less than $1,000.